Alnylam is launching coordinated initiatives to a

Preprint RCT in healthy adults suggests multi-ta

Partners expand beyond initial sarcopenia progra

New tool harnesses data from multiple sources to

New preclinical data suggest Galimedix may have

Company aims to give AI much broader map of life

Anavex Life Sciences presented new data from its

NeuroRPM’s FDA-cleared wearable platform will b

ProMIS Neurosciences presented two scientific pos

Unlimited Bio registered a Phase 1/2a clinical tr

Fauna Bio announced the designation of a target u

Garm LLC, doing business as Longevity Advanced, u

RevGenetics launched DiBerberine 300x, an enteric

A peer-reviewed study published in March 2026 by

Elitra Health announced on 20 March 2026 that it

Why aging science built around male biology keep

New study shows Gen X and Millennials face risin

New precompetitive effort aims to standardize ho

Results suggest ABBV-295 could expand the next g

Daily oral PCSK9 drug could make powerful heart

Swedish biotech doses first subjects in new ATR-

Fresh funding will help Cambridge startup turn v

AlzeCure presented new preclinical data on its Ne

Totus Medicines presented Phase 1a clinical data

Aspen Neuroscience presented 12-month safety, tol

Researchers pinpoint the exact neurons hit harde

Early recognition for Behcet’s disease undersc

German biotech launches the first CE-certified P

ImmunoBrain presented Phase 1b results for IBC-Ab

Showing at AD/PD 2026 signals blood-based Alzhei

Origami Therapeutics CEO on harnessing autophagy

New biotech R1 Therapeutics emerges with fresh b

Longevity.

New research connects sustained neurogenesis and

Telehealth platform Wisp launches a new healthy

ADDF launched the third phase of its Diagnostics

Serina Therapeutics has entered definitive agreem

Company designates target in metabolic disease p

Edinburgh scientists use engineered bacteria to

How DLT’s chatbot turns fragmented public mark

Today we are lifting the lid on what this really

High-stakes debate and hackathon will probe brai

UT Health San Antonio readies for $38 million hu

Surprise cancelation of leading aging conference

Alchemab Therapeutics has appointed Ulrich Wendt,

Cellino has appointed Ed Tekeian as Chief Operati

Cognition Therapeutics presented an analysis from

Anavex Life Sciences presented new preclinical da

Parallel Health has introduced a new technology d

Cognito Therapeutics presented new data on its in